Health
Phase 1 trial results of gorilla adenovirus vaccine for COVID-19 – News-Medical.Net
A recent study published on the preprint server bioRxiv* in October 2020 reports the development of a novel vaccine based on a simian adenoviral vector obtained…
A recent study published on the preprint server bioRxiv* in October 2020 reports the development of a novel vaccine based on a simian adenoviral vector obtained from a group C gorilla isolate called GRAd32. This could help speed up vaccine development.
Low Seroprevalence for Simian Adenoviruses
Simian adenoviruses are isolated from non-human primates like the chimpanzee and gorilla and do not infect humans. Their prevalence is, therefore, low or non-existent among humans. They have been used to…
-
Noosa News23 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News23 hours agoE-biker charged with riding dangerously, assaulting cop
-
Business17 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General22 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands